These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 28323510

  • 1. Positive association between the changes in chemerin and adiponectin levels after weight reduction.
    Shin HY, Park S, Lee JW.
    Endocr Res; 2017 Nov; 42(4):287-295. PubMed ID: 28323510
    [Abstract] [Full Text] [Related]

  • 2. Exercise-Induced Weight Loss is More Effective than Dieting for Improving Adipokine Profile, Insulin Resistance, and Inflammation in Obese Men.
    Khoo J, Dhamodaran S, Chen DD, Yap SY, Chen RY, Tian RH.
    Int J Sport Nutr Exerc Metab; 2015 Dec; 25(6):566-75. PubMed ID: 26011919
    [Abstract] [Full Text] [Related]

  • 3. [Pharmacological therapy of obesity].
    Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [Abstract] [Full Text] [Related]

  • 4. Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines.
    Valsamakis G, McTernan PG, Chetty R, Al Daghri N, Field A, Hanif W, Barnett AH, Kumar S.
    Metabolism; 2004 Apr; 53(4):430-4. PubMed ID: 15045687
    [Abstract] [Full Text] [Related]

  • 5. Effects of sibutramine and orlistat on mood in obese and overweight subjects: a randomised study.
    Kiortsis DN, Tsouli S, Filippatos TD, Konitsiotis S, Elisaf MS.
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):207-10. PubMed ID: 17570651
    [Abstract] [Full Text] [Related]

  • 6. Sibutramine improves insulin sensitivity without alteration of serum adiponectin in obese subjects with Type 2 diabetes.
    Hung YJ, Chen YC, Pei D, Kuo SW, Hsieh CH, Wu LY, He CT, Lee CH, Fan SC, Sheu WH.
    Diabet Med; 2005 Aug; 22(8):1024-30. PubMed ID: 16026368
    [Abstract] [Full Text] [Related]

  • 7. Impact of weight loss on adipocytokines, C-reactive protein and insulin sensitivity in hypertensive women with central obesity.
    Borges RL, Ribeiro-Filho FF, Carvalho KM, Zanella MT.
    Arq Bras Cardiol; 2007 Dec; 89(6):409-14. PubMed ID: 18317625
    [Abstract] [Full Text] [Related]

  • 8. Decrease in serum chemerin through aerobic exercise plus dieting and its association with mitigation of cardio-metabolic risk in obese female adolescents.
    Liu M, Lin X, Wang X.
    J Pediatr Endocrinol Metab; 2018 Jan 26; 31(2):127-135. PubMed ID: 29306931
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity.
    Gokcel A, Gumurdulu Y, Karakose H, Melek Ertorer E, Tanaci N, BascilTutuncu N, Guvener N.
    Diabetes Obes Metab; 2002 Jan 26; 4(1):49-55. PubMed ID: 11874442
    [Abstract] [Full Text] [Related]

  • 10. The association between chemerin and homeostasis assessment of insulin resistance at baseline and after weight reduction via lifestyle modifications in young obese adults.
    Lee MK, Chu SH, Lee DC, An KY, Park JH, Kim DI, Kim J, Hong S, Im JA, Lee JW, Jeon JY.
    Clin Chim Acta; 2013 Jun 05; 421():109-15. PubMed ID: 23485648
    [Abstract] [Full Text] [Related]

  • 11. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
    Yang S, Wang Q, Huang W, Song Y, Feng G, Zhou L, Tan J.
    Gynecol Endocrinol; 2016 Jun 05; 32(1):38-41. PubMed ID: 26291816
    [Abstract] [Full Text] [Related]

  • 12. Comparison of efficacy of sibutramine or orlistat versus their combination in obese women.
    Sari R, Balci MK, Cakir M, Altunbas H, Karayalcin U.
    Endocr Res; 2004 May 05; 30(2):159-67. PubMed ID: 15473126
    [Abstract] [Full Text] [Related]

  • 13. The effects of sibutramine and orlistat on the ultrasonographic findings, insulin resistance and liver enzyme levels in obese patients with non-alcoholic steatohepatitis.
    Sabuncu T, Nazligul Y, Karaoglanoglu M, Ucar E, Kilic FB.
    Rom J Gastroenterol; 2003 Sep 05; 12(3):189-92. PubMed ID: 14502318
    [Abstract] [Full Text] [Related]

  • 14. Effect of diet and diet combined with chronic aerobic exercise on chemerin plasma concentrations and adipose tissue in obese women.
    Lakhdar N, Landolsi M, Bouhlel E, Tabka Z.
    Neuro Endocrinol Lett; 2019 Dec 05; 40(6):262-270. PubMed ID: 32200585
    [Abstract] [Full Text] [Related]

  • 15. Orlistat, sibutramine, or combination therapy: which performs better on waist circumference in relation with body mass index in obese patients?
    Aydin N, Topsever P, Kaya A, Karasakal M, Duman C, Dağar A.
    Tohoku J Exp Med; 2004 Mar 05; 202(3):173-80. PubMed ID: 15065643
    [Abstract] [Full Text] [Related]

  • 16. Comparison of orlistat and sibutramine in an obesity management program: efficacy, compliance, and weight regain after noncompliance.
    Gursoy A, Erdogan MF, Cin MO, Cesur M, Baskal N.
    Eat Weight Disord; 2006 Dec 05; 11(4):e127-32. PubMed ID: 17272944
    [Abstract] [Full Text] [Related]

  • 17. Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity.
    Chakaroun R, Raschpichler M, Klöting N, Oberbach A, Flehmig G, Kern M, Schön MR, Shang E, Lohmann T, Dreßler M, Fasshauer M, Stumvoll M, Blüher M.
    Metabolism; 2012 May 05; 61(5):706-14. PubMed ID: 22136911
    [Abstract] [Full Text] [Related]

  • 18. Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).
    Vosnakis C, Georgopoulos NA, Rousso D, Mavromatidis G, Katsikis I, Roupas ND, Mamali I, Panidis D.
    Gynecol Endocrinol; 2013 Mar 05; 29(3):242-5. PubMed ID: 23194076
    [Abstract] [Full Text] [Related]

  • 19. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.
    Elfhag K, Finer N, Rössner S.
    Diabetes Obes Metab; 2008 Jun 05; 10(6):498-505. PubMed ID: 17593239
    [Abstract] [Full Text] [Related]

  • 20. Effect of weight loss with or without orlistat treatment on adipocytokines, inflammation, and oxidative markers in obese women.
    Bougoulia M, Triantos A, Koliakos G.
    Hormones (Athens); 2006 Jun 05; 5(4):259-69. PubMed ID: 17178701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.